| 摘要 |
A pharmaceutical composition for use in the treatment of gastrointestinal disorders comprising 1,2,3,9-tetrahydro -9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one or a physiologically acceptable salt or solvate thereof and ranitidine or a physiologically acceptable salt thereof.
|
